Healthcare -
Biotechnology - NASDAQ - US
$ 7.485
-7.02 %
$ 5.21 M
Market Cap
0.0
P/E
RNAZ - COST OF REVENUE
Cost of Revenue RNAZ - TransCode Therapeutics, Inc.
517 K
LAST VALUE
248.82%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR